Neurology
Main Filters
Neurology
| Cardinal Health | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 26-5342I | 0 | - | ||
| PN11CLS25 | 0 | - | ||
| PN11NEXX4 | 0 | - | ||
| PN23SNB17 | 0 | - | ||
| PN30LMP17 | 0 | - | ||
| PN33CFAD8 | 0 | - | ||
| PN33LMAD5 | 0 | - | ||
| PN76CRH21 | 0 | - | ||
| PNCGACA25 | 0 | - | ||
| PNCGLLBM6 | 0 | - | ||
| PNHDFSV10 | 0 | - | ||
| PNV2SFCP6 | 0 | - | ||
| PNVMSUA215 | 0 | - | ||
| PNVMTR219 | 0 | - | ||
| PNVPLM015 | 0 | - | ||
| SAN21NAPM9 | 0 | - | ||
| SNE11CFS23 | 0 | - | ||
| SNE11IRLV2 | 0 | - | ||
| SNE11LMJ21 | 0 | - | ||
| SNE11NRU17 | 0 | - | ||
| SNE11SPJ10 | 0 | - | ||
| SNE11SPMKE | 0 | - | ||
| SNE12CF310 | 0 | - | ||
| SNE12CF34D | 0 | - | ||
| SNE12SUG17 | 0 | - | ||
| SNE13NLGL1 | 0 | - | ||
| SNE22RNM35 | 0 | - | ||
| SNE26CRHR6 | 0 | - | ||
| SNE32CRSP9 | 0 | - | ||
| SNE33CR517 | 0 | - | ||
| SNE35NE311 | 0 | - | ||
| SNE40CPK18 | 0 | - | ||
| SNE43LNOG4 | 0 | - | ||
| SNE43NPM13 | 0 | - | ||
| SNE44OMMDH | 0 | - | ||
| SNE53LPPV4 | 0 | - | ||
| SNE69CNMR8 | 0 | - | ||
| SNE73LMHP6 | 0 | - | ||
| SNECGACRO5 | 0 | - | ||
| SNECGCRRI9 | 0 | - | ||
| SNECGNSEBF | 0 | - | ||
| SNECGSTBO2 | 0 | - | ||
| SNEDHCRCF6 | 0 | - | ||
| SNEDKCPRP4 | 0 | - | ||
| SNEHDCRG11 | 0 | - | ||
| SNEOCNEBYA | 0 | - | ||
| SNEOCNUBYA | 0 | - | ||
| SNEOCSPBK3 | 0 | - | ||
| PEAR THERAPEUTICS, INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 1 | 0 | - | ||
| 1 | 0 | - | ||
124,192 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
reSET-O® Non-Monetary CM
PEAR THERAPEUTICS, INC.
reSET-O is intended to increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic. This configuration of reSET-O is intended to provide virtual incentives to patients based on the Contingency management system.
0
-
reSET-O®
PEAR THERAPEUTICS, INC.
reSET-O is intended to increase retention of patients with Opioid Use Disorder (OUD) in outpatient treatment by providing cognitive behavioral therapy, as an adjunct to outpatient treatment that includes transmucosal buprenorphine and contingency management, for patients 18 years or older who are currently under the supervision of a clinician. reSET-O is indicated as a prescription-only digital therapeutic. This configuration of reSET-O is intended to provide virtual incentives as well as monetary incentives to the patients based on the Contingency management system.